Thanks, Madam Chair. I can only speak to it from a contractual perspective.
We have enough vaccines under contract for the two approved vaccines to get all Canadians vaccinated. We have delivery schedules that will get us there by the end of September. As more vaccines get approved—should they get approved—we have a chance to improve on that.
It is a steady ramp-up of deliveries. These are production lines that are still relatively new, so it makes perfect sense that early Q1 deliveries will be smaller than Q2's. This is a steady ramp-up, and there are enough vaccines under contract for already approved vaccines.